Skip to content

Our mission

Finding better, more personalized treatment & diagnostic options for people with unmet medical needs

Complex, chronic diseases are difficult to diagnose, expensive to manage, and often lack effective treatments. They represent the biggest challenge to health – affecting billions of patients and accounting for over 80% of global healthcare spending.

We bring the benefits of precision medicine affordably into routine clinical practice and R&D for these most common and costly diseases.

Predicting and preventing chronic diseases to improve patient outcomes and reduce health costs.

This is PrecisionLife.

"To truly understand, predict and prevent complex diseases, we must move beyond symptom-based labels and adopt a fundamentally mechanistic view of biology – just as we did to transform cancer care into precision medicine."

"PrecisionLife leads the world in identifying the mechanisms of disease and turning insights into clinically actionable solutions to reduce the global burden of chronic disease."

Steve Gardner quote-min-1

Steve Gardner, PhD
CEO & Co-founder, PrecisionLife

2.ALZHEIMERS-min

A new era of precision medicine

Chronic diseases are caused by a complex interplay of multiple genes and heterogeneous factors. Their complexity means that patients with the same diagnosis may have different drivers of disease and will benefit from different therapies.

These differences cannot be understood by traditional genomic analyses such as GWAS, polygenic risk scores, generative AI, or panel-based diagnostics.

Therefore, while oncology has been transformed by precision medicine, more prevalent and expensive chronic diseases have not.

Until now...

Putting people at the center of their health

We've completely reimagined how to analyze patient data.

Using our Combinatorial Analytics & AI platform we are the first company to understand and stratify complex disease biology – identifying the mechanistic causes of disease in individual patients.

This allows us to create more personalized diagnostic tools, therapy options and clinical pathways, and to find the right patients for new trials and treatments based on their biology.

Increasing success for clinical trials, treatments and patients.

Patients at center of their health (2)-min (1)
Discover develop and launch precision medicine-min (1)

Clinically actionable insights

We bring precision to every stage of the biopharma and healthcare value chain – guided by our unique insights into the mechanisms driving disease to connect the right patients with the right targets, trials and treatments.

A snapshot of our progress

Driving precision medicine in complex, chronic diseases

World-leading science


10x signal from 10% of data

Our platform is world-leading – identifying causal biology, the holy grail of precision medicine, in over 60 complex diseases.

Improving global health


>5 Billion patients lives

Our clinical research studies have created new precision medicine opportunities for diseases that affect 5.4B people.

 

Proprietary disease insights


>100K protectable IP assets

We've created the most valuable repository of chronic disease insights, including biomarkers, risk models, and novel targets.

Rapid reduction to practice


Reducing the cost of healthcare

Our mechanostic tests identify disease risk for earlier, more personalized intervention and prevention of chronic diseases.

Our science

We've completely reimagined how to analyze multiomic patient data to stratify complex chronic disease biology at unprecedented resolution – driving precision medicine.

Our team

Led by Dr Steve Gardner, a global leader in precision medicine & human genetics, and supported by a leadership team with vast experience and expertise.